Half Year 2023 Transgene SA Earnings Call Transcript

Sep 20, 2023 / 04:00PM GMT
Operator

Hello, and welcome to the Transgene First Half 2023 Financial Results and Business Update Call. Please note, this conference is being recorded. (Operator Instructions) . I will now hand you over to your host, Lucie Larguier, to begin today's conference. Thank you.

Lucie Larguier - Transgene SA - VP of Corporate Communication & IR

Thank you, [Francois]. Hello, everyone, I'm Lucie, Director of IR Transgene. I have the pleasure today to introduce you to Dr. Alessandro Riva, our Chairman and CEO along with several members of the Executive Committee. So you will have Eric Quéméneur, our CFO; Maud Brandely, Chief Medical Officer; Jean-Philippe Del, CFO; and Christophe Ancel, VP Pharmaceutical Operations. We will review today's news regarding on the progress of the first half of this year and answer any questions you may have.

Before I turn over the call to Alessandro, I'd like to remind everyone that today's discussion contains forward-looking statements, which are subject to numerous risks and uncertainties. If you listen to this webcast via the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot